In this review
Decide whether the missing help is medical or practical
Try Invigor makes more sense when the job is arranging a clinical assessment and a prescribed treatment from home. Its GLP-1 pages include consultation, supplies and support, and describe online follow-ups. That can remove the need to coordinate those pieces separately. It does not establish a schedule of dietitian appointments, meal planning or behavioral sessions. I would choose it for its documented medical service, then budget separately for any practical help the week still requires. [1] [2]
A person who needs regular help with meals and routines should compare the actual support schedule before choosing a medication platform. Medical staff answering treatment questions can be valuable without supplying the same service as a coach. Paying for both may be reasonable when they solve different problems; expecting one to silently include the other sets up a disappointing purchase.
Match support to the work needed through our coaching-versus-self-directed guide.
Choose the type of practical support through our dietitian, training and tracking comparison.
The headline needs a billing unit
The GLP-1 offer starts at $225, but that headline does not state a billing period. The separate GLP-1 + GIP page starts at $350 per month. A household budget needs the selected prescription, amount charged now, amount charged later and supply period. Comparing $225 directly with another service’s monthly invoice would give the number more meaning than the page establishes. [1] [2]
The terms describe a single total subscription price that can include platform, clinical and pharmacy components. They also allow applicable shipping charges and taxes. Match those terms to the actual order, including any required testing. A consultation listed as included is useful, but it is not permission to assume every future service or outside pharmacy bill is covered. [3]
Put the selected bill and extra help into the full program-cost planner.
Put the renewal processing date in the calendar
Try Invigor requires subscription cancellation at least seven days before renewal processing. Its terms allow the first renewal to be charged early and later charging or shipping up to two days early. A pause ends with automatic charging unless the subscription is canceled. The date to track is the processing date, not when the box is expected to arrive. [3]
For a new order, the refund window closes before the prescription enters the practitioner’s queue. Once practitioner review, prescription processing or pharmacy fulfillment has begun, cancellation or a refund is unavailable under the stated rule. A monthly renewal already notified requires a phone request, with processing status still controlling whether it can be stopped. Someone wanting a flexible one-time trial should resolve that commitment before submitting an order. [3] [4]
For another refill and support arrangement, read our Trava recurring-care review.
Compare programs by the work they actually do
Invigor’s medication disclaimer describes compounded alternatives and says it does not supply FDA-approved brands. Clinical eligibility remains a provider decision. That scope can fit a buyer who understands the treatment and manages the practical routine independently. For someone whose main obstacle is sustained coaching or branded-prescription access, compare a program built around that need instead of choosing from the lowest starting figure. [1] [5] [6]
For a different program structure, compare our WeightWatchers program review.
Understanding the cost
The GLP-1 page shows a $225 starting price without an explicit period. GLP-1 + GIP starts at $350/month. Obtain the actual first/renewal bill, supply period and support scope before comparing household costs.
Build your cost estimateSources
- Try Invigor: GLP-1 clinical service, inclusions and medication disclaimer
- Try Invigor: GLP-1 + GIP price and support
- Try Invigor: subscription billing, clinical roles and order-stage cancellation
- Try Invigor: refund policy and seven-day renewal notice
- Try Invigor: clinical eligibility, follow-up and scope exclusions
- FDA: compounded medicines and approval status
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.